Suppr超能文献

经口机器人手术治疗人乳头瘤病毒阴性口咽鳞状细胞癌:肿瘤学及功能结局随访

Trans Oral Robotic Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma: Follow-Up on Oncological and Functional Outcomes.

作者信息

Azalmad Khalid, Lambercy Karma, Beharry Avinash, Piazzon Nathalie, Barbesier Marie, Dalla-Vale Margaux, Moraru Manuela, Berezowska Sabina, Simon Christian

机构信息

Department of Otolaryngology-Head and Neck Surgery, CHUV, University of Lausanne, Lausanne, Switzerland.

Department of Laboratory Medicine and Pathology, Institute of Pathology, CHUV, University of Lausanne, Lausanne, Switzerland.

出版信息

Head Neck. 2025 Mar;47(3):791-800. doi: 10.1002/hed.27958. Epub 2024 Oct 14.

Abstract

BACKGROUND

The efficacy of transoral robotic surgery (TORS) for HPV-negative oropharyngeal cancers (OPSCC) is less explored, especially regarding long-term outcomes and prognostic factors.

METHODS

We conducted a retrospective monocentric study on 37 patients with HPV-negative OPSCC treated with TORS with a median follow-up of 3 years, assessing survival outcomes using Kaplan-Meyer statistics and swallowing function via the functional outcome swallowing scale (FOSS). Histopathological parameters were collected either from medical records or histology slides were re-evaluated.

RESULTS

Patients demonstrated high disease-specific survival (DSS) but lower overall survival (OS), with a cohort characterized by high comorbidity rates. Vascular invasion was a significant adverse factor for relapse-free survival (RFS) and OS, while lymphatic invasion was not. Most patients demonstrated significant preservation of swallowing function.

CONCLUSIONS

TORS for HPV-negative OPSCC demonstrates high DSS and preserved swallowing function. Vascular invasion is a key prognostic factor for survival outcomes.

摘要

背景

经口机器人手术(TORS)治疗人乳头瘤病毒(HPV)阴性口咽癌(OPSCC)的疗效鲜少被探究,尤其是关于长期预后及预后因素。

方法

我们对37例接受TORS治疗的HPV阴性OPSCC患者进行了一项回顾性单中心研究,中位随访时间为3年,采用Kaplan-Meier统计法评估生存结局,并通过吞咽功能结局量表(FOSS)评估吞咽功能。组织病理学参数要么从病历中收集,要么对组织学切片进行重新评估。

结果

患者显示出较高的疾病特异性生存率(DSS),但总生存率(OS)较低,该队列的特点是合并症发生率高。血管侵犯是无复发生存率(RFS)和OS的显著不利因素,而淋巴侵犯则不是。大多数患者的吞咽功能得到了显著保留。

结论

TORS治疗HPV阴性OPSCC显示出较高的DSS和保留的吞咽功能。血管侵犯是生存结局的关键预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea6/11816564/fa24933a12b2/HED-47-791-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验